Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
D000818:Animals; D002360:Carubicin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002478:Cells, Cultured; D004247:DNA / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004278:DNA, Superhelical / Q000378:metabolism; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004317:Doxorubicin / Q000494:pharmacology*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D013329:Structure-Activity Relationship
D004273:DNA, Neoplasm; D004278:DNA, Superhelical; D012334:RNA, Neoplasm; D004317:Doxorubicin; D004247:DNA; D002360:Carubicin; D003630:Daunorubicin